vs

Side-by-side financial comparison of LINKBANCORP, Inc. (LNKB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $46.0M, roughly 1.8× LINKBANCORP, Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -38.1%, a 44.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 7.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.6%).

LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LNKB vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$46.0M
LNKB
Growing faster (revenue YoY)
PRCT
PRCT
+12.9% gap
PRCT
20.2%
7.3%
LNKB
Higher net margin
LNKB
LNKB
44.5% more per $
LNKB
6.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
6.6%
LNKB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LNKB
LNKB
PRCT
PRCT
Revenue
$46.0M
$83.1M
Net Profit
$2.9M
$-31.6M
Gross Margin
64.9%
Operating Margin
8.5%
-4.1%
Net Margin
6.4%
-38.1%
Revenue YoY
7.3%
20.2%
Net Profit YoY
-61.2%
-27.9%
EPS (diluted)
$0.08
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LNKB
LNKB
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$46.0M
$76.4M
Q3 25
$44.8M
$83.3M
Q2 25
$42.3M
$79.2M
Q1 25
$53.4M
$69.2M
Q4 24
$42.9M
$68.2M
Q3 24
$42.9M
$58.4M
Q2 24
$41.3M
$53.4M
Net Profit
LNKB
LNKB
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$2.9M
$-29.8M
Q3 25
$7.8M
$-21.4M
Q2 25
$7.4M
$-19.6M
Q1 25
$15.3M
$-24.7M
Q4 24
$7.6M
$-18.9M
Q3 24
$7.1M
$-21.0M
Q2 24
$5.8M
$-25.6M
Gross Margin
LNKB
LNKB
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
LNKB
LNKB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
8.5%
-40.6%
Q3 25
22.3%
-27.8%
Q2 25
22.4%
-28.0%
Q1 25
36.0%
-39.7%
Q4 24
22.6%
-28.9%
Q3 24
21.3%
-38.4%
Q2 24
18.0%
-50.3%
Net Margin
LNKB
LNKB
PRCT
PRCT
Q1 26
-38.1%
Q4 25
6.4%
-39.1%
Q3 25
17.5%
-25.7%
Q2 25
17.5%
-24.7%
Q1 25
28.7%
-35.8%
Q4 24
17.7%
-27.6%
Q3 24
16.5%
-35.9%
Q2 24
14.1%
-48.0%
EPS (diluted)
LNKB
LNKB
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.08
$-0.54
Q3 25
$0.21
$-0.38
Q2 25
$0.20
$-0.35
Q1 25
$0.41
$-0.45
Q4 24
$0.21
$-0.34
Q3 24
$0.19
$-0.40
Q2 24
$0.16
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LNKB
LNKB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$52.3M
$245.6M
Total DebtLower is stronger
$177.3M
$51.7M
Stockholders' EquityBook value
$306.4M
$347.7M
Total Assets
$3.1B
$487.1M
Debt / EquityLower = less leverage
0.58×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LNKB
LNKB
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$52.3M
$286.5M
Q3 25
$194.2M
$294.3M
Q2 25
$155.1M
$302.7M
Q1 25
$220.2M
$316.2M
Q4 24
$166.1M
$333.7M
Q3 24
$191.2M
$196.8M
Q2 24
$181.7M
$214.1M
Total Debt
LNKB
LNKB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$177.3M
$51.6M
Q3 25
$102.3M
$51.6M
Q2 25
$102.3M
$51.5M
Q1 25
$102.7M
$51.5M
Q4 24
$112.5M
$51.5M
Q3 24
$102.4M
$51.4M
Q2 24
$102.3M
$51.4M
Stockholders' Equity
LNKB
LNKB
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$306.4M
$365.9M
Q3 25
$305.5M
$380.3M
Q2 25
$298.0M
$385.8M
Q1 25
$294.1M
$389.2M
Q4 24
$280.2M
$402.2M
Q3 24
$277.4M
$241.2M
Q2 24
$271.4M
$251.8M
Total Assets
LNKB
LNKB
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$3.1B
$508.1M
Q3 25
$3.1B
$511.5M
Q2 25
$2.9B
$513.1M
Q1 25
$2.9B
$519.4M
Q4 24
$2.9B
$534.0M
Q3 24
$2.9B
$374.1M
Q2 24
$2.9B
$374.4M
Debt / Equity
LNKB
LNKB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.58×
0.14×
Q3 25
0.33×
0.14×
Q2 25
0.34×
0.13×
Q1 25
0.35×
0.13×
Q4 24
0.40×
0.13×
Q3 24
0.37×
0.21×
Q2 24
0.38×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LNKB
LNKB
PRCT
PRCT
Operating Cash FlowLast quarter
$25.3M
Free Cash FlowOCF − Capex
$23.8M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
8.59×
TTM Free Cash FlowTrailing 4 quarters
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LNKB
LNKB
PRCT
PRCT
Q1 26
Q4 25
$25.3M
$-10.3M
Q3 25
$23.6M
$-6.6M
Q2 25
$6.3M
$-15.0M
Q1 25
$2.6M
$-17.0M
Q4 24
$25.4M
$-32.4M
Q3 24
$14.0M
$-18.8M
Q2 24
$6.4M
$-15.7M
Free Cash Flow
LNKB
LNKB
PRCT
PRCT
Q1 26
Q4 25
$23.8M
$-12.2M
Q3 25
$23.2M
$-9.5M
Q2 25
$6.1M
$-17.8M
Q1 25
$2.2M
$-18.8M
Q4 24
$22.6M
$-33.6M
Q3 24
$13.1M
$-19.0M
Q2 24
$6.3M
$-16.8M
FCF Margin
LNKB
LNKB
PRCT
PRCT
Q1 26
Q4 25
51.7%
-15.9%
Q3 25
51.8%
-11.4%
Q2 25
14.5%
-22.5%
Q1 25
4.2%
-27.2%
Q4 24
52.6%
-49.2%
Q3 24
30.5%
-32.6%
Q2 24
15.3%
-31.4%
Capex Intensity
LNKB
LNKB
PRCT
PRCT
Q1 26
Q4 25
3.2%
2.4%
Q3 25
0.8%
3.4%
Q2 25
0.4%
3.5%
Q1 25
0.7%
2.7%
Q4 24
6.7%
1.7%
Q3 24
2.1%
0.4%
Q2 24
0.1%
2.0%
Cash Conversion
LNKB
LNKB
PRCT
PRCT
Q1 26
Q4 25
8.59×
Q3 25
3.01×
Q2 25
0.85×
Q1 25
0.17×
Q4 24
3.35×
Q3 24
1.97×
Q2 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LNKB
LNKB

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons